MMWR Vol. 64 / No. RR-2 ► Clinical Guidance for Smallpox Vaccine Use in a Postevent Vaccination Program

MMWR Vol. 64 / No. RR-2

MMWR Recommendations and Reports Vol. 64, No. RR-2 February 20, 2015

PDFClinical Guidance for Smallpox Vaccine Use in a Postevent Vaccination Program  Petersen BW, Damon IK, Pertowski CA, et al. MMWR Recomm Rep 2015;64(No. RR-2)  This report outlines recommendations for the clinical use of the three smallpox vaccines stored in the U.S. Strategic National Stockpile for persons who are exposed to smallpox virus or at high risk for smallpox infection during a postevent vaccination program following an intentional or accidental release of the virus. These recommendations will be updated as new data on smallpox vaccines become available and as further clinical guidance for other medical countermeasures including antivirals is developed.Clinical Guidance for Smallpox Vaccine Use in a Postevent Vaccination Program